Diabetes could be a risk factor for severity in patients with Covid-19. Acute respiratory distress syndrome and Disseminated Intravascular Coagulation usually occur in the second week of the disease, concomitantly with cytokine storm and hypercoagulable state [@b0005].

Diabetes could contribute to the loss of capacity to regulate immunity. The dysfunction of the autonomic nervous system might determine the pro-inflammatory state in diabetic Covid-19 patients, as a result of a dysregulation of the inflammatory reflex, where vagal afferent fibres, receiving sensory inputs from the immune cells, activate vagal efferent fibres, responsible for mitigating macrophage activation [@b0010].

Furthermore, diabetes is associated with structural alterations in the lung, as the thickening of the pulmonary basal laminae and of the alveolar epithelium, concurrent with reduction of DLCO [@b0015]. Other aspects are a higher prevalence of a restrictive spirometry pattern and a decreased respiratory muscle endurance [@b0020]. These abnormalities might worsen conditions associated with increased pulmonary demands, such as respiratory infections [@b0020]. In addition, Diabetic Autonomic Neuropathy could induce functional alterations in the regulation of bronchomotor tone and in the control of ventilation [@b0015].

Finally, diabetes mellitus is considered a pro-thrombotic state in which hyperglycemia and inflammation directly contribute to abnormal platelet activation, higher concentration of fibrinogen and other coagulation factors [@b0025]. Moreover generation of AGEs and ROS leads to an endothelial injury, with an increased levels and structural alterations in von Willebrand factor, that are associated with thrombotic angiopathies [@b0030]. In Covid-19, which may be associated with both venous and arterial thromboembolic disease, due to inflammation, hypoxia, immobilization, and disseminated intravascular coagulation [@b0035], diabetes could further contribute to hypercoagulable state.
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